Datamonitor Healthcare: data analysis and insight, Scrip: in...
The tumor-agnostic developer’s toolkit
Using real-time development, pipeline event and impact tracking, and in-depth disease and market landscape reports, this webinar looks at the market dynamics, opportunities, threats, and payer pressures for marketed HIV drugs, and examines the likelihood of approval for late-phase pipeline drugs.
Mr. Haydock & Mr. Haas used the exclusive information within Datamonitor Healthcare and Biomedtracker to present a view of the market for HIV drugs. Informa Pharma Intelligence forecasts HIV sales revenues to increase in the US and five major EU markets to a peak of $22.7bn in 2024 before generic erosion triggers a market decline.
In this recording you will learn about the significant market shifts. It covers:
Biomedtracker: follow the drug development process , Datamon...
Anticipate the biggest, most impactful expected catalysts of early 2020 with the guidance and insights from Pharma Intelligence. Building off Biomedtracker’s Early 2020 Outlook report, our live webinar will include market context for these upcoming milestones and additional insights from Datamonitor Healthcare’s Therapeutic Area Directors.
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Our team is always happy to hear from you. Please call us at:
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: